Ocumension Therapeutics (Suzhou) Co., Ltd
2 clinical trials · Sponsor
◉ Watch Ocumension Therapeutics (Suzhou) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Phase III Study of OT202 in Treating Moderate to Severe Dry Eye (NCT07740564) | Ocumension Therapeutics (Suzhou) Co., Ltd | 2026-08-01 |
| Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children (NCT06697522) | Ocumension Therapeutics (Suzhou) Co., Ltd | 2023-06-25 |
Track Ocumension Therapeutics (Suzhou) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.